{{Rsnum
|rsid=1806649
|Gene=NFE2L2
|Chromosome=2
|position=177253424
|Orientation=plus
|GMAF=0.1382
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.9 | 38.1 | 7.1
| HCB | 85.4 | 14.6 | 0.0
| JPT | 89.4 | 10.6 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 85.4 | 14.6 | 0.0
| CHD | 78.0 | 21.1 | 0.9
| GIH | 87.1 | 11.9 | 1.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 72.4 | 25.9 | 1.7
| MKK | 85.3 | 14.1 | 0.6
| TSI | 49.0 | 40.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22531667
|Title=PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics
}}

{{PMID Auto
|PMID=24528044
|Title=Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients
}}

{{PMID Auto
|PMID=19671143
|Title=Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
|OA=1
}}

{{PMID Auto
|PMID=20196834
|Title=Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}